IBB
iShares Biotechnology ETF
iShares Biotechnology ETF 13F Holders
IBB Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $310.08
- Current price*:
- -36.71%($196.26)
1 value investing guru has made changes to the iShares Biotechnology ETF (IBB) position according to the gurus' 2017 Q3 SEC quarterly report(s). IBB has been completely sold out by 1 guru(s)
Which gurus or hedge funds bought IBB in 2017 Q3?
According to the 2017 Q3 SEC filing(s) iShares Biotechnology ETF (IBB) has not been purchased by any super investor.
To see more about who is investing in iShares Biotechnology ETF (IBB), please go to the IBB ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.